130 related articles for article (PubMed ID: 14706339)
1. Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene.
Fleischmann A; Jochum W; Eferl R; Witowsky J; Wagner EF
Cancer Cell; 2003 Dec; 4(6):477-82. PubMed ID: 14706339
[TBL] [Abstract][Full Text] [Related]
2. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
Jochum W
Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcomagenesis-Novel pathway found.
Asakura A; Rudnicki MA
Cancer Cell; 2003 Dec; 4(6):421-2. PubMed ID: 14706332
[TBL] [Abstract][Full Text] [Related]
4. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
[TBL] [Abstract][Full Text] [Related]
5. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
[TBL] [Abstract][Full Text] [Related]
6. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
[TBL] [Abstract][Full Text] [Related]
7. Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology.
Matsuo K; Ray N
Keio J Med; 2004 Jun; 53(2):78-84. PubMed ID: 15247511
[TBL] [Abstract][Full Text] [Related]
8. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis.
Liebermann DA; Gregory B; Hoffman B
Int J Oncol; 1998 Mar; 12(3):685-700. PubMed ID: 9472112
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
Langfermann DS; Rössler OG; Thiel G
Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase II is an AP-1 target gene in osteoclasts.
David JP; Rincon M; Neff L; Horne WC; Baron R
J Cell Physiol; 2001 Jul; 188(1):89-97. PubMed ID: 11382925
[TBL] [Abstract][Full Text] [Related]
12. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of the rat steroidogenic acute regulatory (StAR) protein gene by the AP-1 family member c-Fos.
Shea-Eaton W; Sandhoff TW; Lopez D; Hales DB; McLean MP
Mol Cell Endocrinol; 2002 Feb; 188(1-2):161-70. PubMed ID: 11911955
[TBL] [Abstract][Full Text] [Related]
14. Activator protein-1 activity regulates epithelial tumor cell identity.
Gerdes MJ; Myakishev M; Frost NA; Rishi V; Moitra J; Acharya A; Levy MR; Park SW; Glick A; Yuspa SH; Vinson C
Cancer Res; 2006 Aug; 66(15):7578-88. PubMed ID: 16885357
[TBL] [Abstract][Full Text] [Related]
15. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
16. c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells.
Liu G; Ding W; Liu X; Mulder KM
Mol Carcinog; 2006 Aug; 45(8):582-93. PubMed ID: 16637060
[TBL] [Abstract][Full Text] [Related]
17. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
[TBL] [Abstract][Full Text] [Related]
20. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic beta cells.
Glauser DA; Schlegel W
FASEB J; 2007 Oct; 21(12):3240-9. PubMed ID: 17504975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
